数据日期 2026-10-29 · 生成时间 2026-10-29 06:03
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
Ageing is an important determinant of immune function across the lifespan, yet it remains underappreciated in the design and interpretation of much basic T cell research.
方法
These controls are indispensable, but the field has built much of its pre-clinical logic on immune systems that are younger, fitter, and biologically distinct from the patients for whom T cell therapies are intended.
核心结论
This issue is particularly acute because many fundamental studies still rely on T cells from, mostly, healthy young donors. ‖ 结论：As the immune system ages, T cell responses become less diverse, less efficient, and less adaptable, with consequences for infection control, vaccine responsiveness, cancer immunosurveillance, and the performance of T cell-based immunotherapies.
局限
未能获取全文，具体设计细节、失访与统计学处理无法核验。
对本项目的价值
★★☆☆☆ 炎症衰老是几乎所有慢性老年病的公共通路，也是最有希望做"抗炎但保留免疫"解耦的靶点。
原文题录
- 英文标题：T cell metabolic ageing as a factor for therapeutic research.
- 期刊与标识：Clin Exp Immunol · PMID 42935129 · DOI 10.1093/cei/uxag066**
A 级证据分级：A 级（同行评议人体研究）
本文属人体研究证据，但需注意：观察性或小样本干预的结论不等于已证实临床获益；效应量与长期安全性仍需更大规模、更长随访的试验验证。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。